Company Filing History:
Years Active: 2023
Title: Michael J. Regan: Innovator in 3D Pharmaceutical Printing
Introduction
Michael J. Regan is an accomplished inventor based in Singapore, renowned for his groundbreaking work in the field of pharmaceutical technology. He holds one patent that exemplifies his innovative spirit and commitment to advancing healthcare solutions through technology.
Latest Patents
Regan's patent focuses on a pioneering method for three-dimensional (3D) printing of pharmaceutical tablets. The innovation involves the use of build material granules that comprise a progression of excipient particles, with at least one acting as a latent binder. By applying pressure to these granules and selectively introducing an activation solvent, he facilitates the formation of pharmaceutical tablets infused with active ingredients. The entire process culminates with the evaporation of the activation solvent, presenting a novel approach to tablet manufacturing that enhances precision and efficacy.
Career Highlights
Michael J. Regan is currently employed with Hewlett-Packard Development Company, L.P., where he leverages his expertise in technology and innovation. His involvement in state-of-the-art 3D printing technology reflects his dedication to improving pharmaceutical manufacturing methods. Regan's work not only contributes to the advancement of the industry but also has significant implications for patient care and medication delivery.
Collaborations
Throughout his career, Regan has collaborated with notable colleagues in the field, including Vladek P. Kasperchik and Michael G. Monroe. These partnerships have provided a dynamic environment for knowledge exchange and innovation, further enhancing the impact of their collective work within the industry.
Conclusion
Michael J. Regan stands out as a visionary inventor in the realm of pharmaceutical advancements through 3D printing. His patent showcases the potential of combining technology with healthcare, paving the way for future innovations in medication production and delivery. As he continues to work with leading industry figures at Hewlett-Packard Development Company, L.P., the implications of his work promise to shape the future of pharmaceutical manufacturing significantly.